Perspective Therapeutics: GuRu Wireless Transforms Drone Operations with Wireless Energy Transfer Technology
- GuRu Wireless showcases wireless energy transfer technology, enabling drones to fly indefinitely without battery replacements.
- CEO Narbeh Derhacobian highlights enhanced operational capabilities for defense and public safety missions using sUAS.
- Founded in 2017, GuRu develops end-to-end drone solutions, significantly improving flight and ISR capabilities.
Revolutionizing Drone Operations: GuRu Wireless Unveils Groundbreaking Wireless Energy Transfer Technology
GuRu Wireless, Inc. makes a significant impact in the field of unmanned aerial systems (UAS) with its recent demonstration of innovative wireless energy transfer technology at the Army Aviation Unmanned Aircraft Systems & Launched Effects Industry Day on February 10, 2025. This event, held at Fort Novosel, Alabama, serves as a platform for showcasing advancements crucial to national security and defense applications. GuRu’s proprietary technology, which operates on a scalable 24GHz wireless power transfer platform, enables small unmanned aerial systems (sUAS) to remain airborne indefinitely, effectively eliminating the need for battery replacements or recharging. This capability marks a pivotal shift in the operational efficiency of drones, particularly for missions requiring extended flight times.
CEO Narbeh Derhacobian emphasizes that GuRu's technology addresses long-standing challenges associated with wireless energy transfer. By facilitating continuous power supply to sUAS, the company enhances the operational capabilities of these systems, enabling them to undertake critical missions in defense, national security, and public safety without the limitations imposed by traditional battery systems. The potential applications of this technology extend beyond military use, impacting various sectors where persistent aerial surveillance and data collection are essential.
Founded in 2017 by a team of experts from Caltech, GuRu Wireless has a robust track record of conducting proof-of-concept projects across industrial, commercial, and defense sectors. In 2024, the company embarked on developing comprehensive end-to-end solutions to further enhance persistent flight and ISR (Intelligence, Surveillance, and Reconnaissance) capabilities via sUAS. The introduction of Long-range Wireless Power Beaming (LRWPB) technology signifies a substantial advancement in drone capabilities, paving the way for more effective and efficient operations in various critical fields.
In addition to its technological advancements, GuRu Wireless is bolstered by strategic investors from leading deep technology firms, demonstrating confidence in its innovative solutions. The company invites interested parties to learn more about its groundbreaking technology through its website and social media channels, where the demonstration of its wireless energy transfer can also be viewed online. As GuRu Wireless continues to push the boundaries of what is possible in drone technology, it solidifies its position as a leader in the rapidly evolving landscape of unmanned systems.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…

